The bad times that the Indian pharmaceutical industry has been facing overseas are about to turn worse. Lupin Ltd, Matrix Laboratories and Niche Generics, the
The European Union’s antitrust regulator, the European Commission, said the three Indian companies, along with France’s Les Laboratories Servier, Israel-based Teva Laboratories and Krka Group, had entered into agreements to delay the entry of generic versions of Perindopril, on which Laboratories Servier had the patent. The market in
The drug regulators in the US and Europe have in recent times raised question marks over the practices followed by some big Indian drug makers. The European Commission had started these investigations 18 months ago, following complaints that non-branded drugs were slow coming into the market because generic drug makers were teaming with patent holding companies to delay launches.
crackcrackCompany Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |